Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T. Le, Luis A. Díaz, Steve Lu et al.|Science|2017Cited by 6.6k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G. Duffy, Tim F. Greten, Susanna V. Ulahannan et al.|Journal of Hepatology|2016Cited by 817
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancerAustin G. Duffy, Tim F. Greten|International Journal of Cancer|2016Cited by 73